SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001176256-19-000176
Filing Date
2019-05-22
Accepted
2019-05-21 19:03:07
Documents
12
Period of Report
2019-05-21

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER FOR THE MONTH OF MAY 2019 correviopharma6kmpm.htm 6-K 6682
2 NOTICE OF ANNUAL MEETING OF SHAREHOLDERS exhibit99-1.htm EX-99.1 5395
3 MANAGEMENT INFORMATION CIRCULAR exhibit99-2.htm EX-99.2 343197
4 FORM OF PROXY exhibit99-3.htm EX-99.3 25255
5 VOTING INSTRUCTIONS FORM exhibit99-4.htm EX-99.4 26181
6 NI CARD exhibit99-5.htm EX-99.5 12872
7 exhibit99-2x3x1.jpg GRAPHIC 2251
8 exhibit99-2x21x1.jpg GRAPHIC 56278
9 exhibit99-3x1x1.jpg GRAPHIC 4433
10 exhibit99-3x1x2.jpg GRAPHIC 15900
11 exhibit99-5x2x2.jpg GRAPHIC 746
12 cpulogo.jpg GRAPHIC 4433
  Complete submission text file 0001176256-19-000176.txt   537265
Mailing Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7
Business Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7 1-604-677-6905
Correvio Pharma Corp. (Filer) CIK: 0001036141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-29338 | Film No.: 19843671
SIC: 2834 Pharmaceutical Preparations